OraSure Technologies to Participate at the Lazard Capital Markets 5th Annual Healthcare Conference
17 Novembre 2008 - 3:22PM
Business Wire
OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that
Douglas A. Michels, President and Chief Executive Officer, will
speak to the investment community at the Lazard Capital Markets
Fifth Annual Healthcare Conference in New York City at
approximately 9:30 am Eastern Time, (6:30 am Pacific Time) on
Wednesday, November 19, 2008. The conference will be simultaneously
webcast over the Internet. Interested investors can access the live
audio webcast of the discussion by going to OraSure Technologies�
web site, www.orasure.com, and clicking on the Investor Information
link. A replay of the audio webcast will be available until
November 26, 2008, on OraSure Technologies� web site. About OraSure
Technologies OraSure Technologies develops, manufactures and
markets oral fluid specimen collection devices using proprietary
oral fluid technologies, diagnostic products including immunoassays
and other in vitro diagnostic tests, and other medical devices.
These products are sold in the United States as well as
internationally to various clinical laboratories, hospitals,
clinics, community-based organizations and other public health
organizations, distributors, government agencies, physicians�
offices, and commercial and industrial entities. OraSure
Technologies is the leading supplier of oral-fluid collection
devices and assays to the life insurance industry and public health
markets for the detection of antibodies to HIV. In addition, the
Company supplies oral-fluid testing solutions for drugs of abuse
testing. For more information on the Company, please go to
www.orasure.com.
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Ott 2023 a Ott 2024